These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6296186)

  • 21. Excess mineralocorticoid receptor activity in patients with dexamethasone-suppressible hyperaldosteronism is under adrenocorticotropin control.
    Speiser PW; Martin KO; Kao-Lo G; New MI
    J Clin Endocrinol Metab; 1985 Aug; 61(2):297-302. PubMed ID: 2989319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors.
    Armanini D; Karbowiak I; Funder JW
    Clin Endocrinol (Oxf); 1983 Nov; 19(5):609-12. PubMed ID: 6315264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of steroids to mineralocorticoid receptors: implications for in vivo occupancy by glucocorticoids.
    Lan NC; Graham B; Bartter FC; Baxter JD
    J Clin Endocrinol Metab; 1982 Feb; 54(2):332-42. PubMed ID: 6274900
    [No Abstract]   [Full Text] [Related]  

  • 24. Excretion of electrolytes in Brown Norway and Fischer 344 rats: effects of adrenalectomy and of mineralocorticoid and glucocorticoid receptor ligands.
    Marissal-Arvy N; Mormède P
    Exp Physiol; 2004 Nov; 89(6):753-65. PubMed ID: 15364879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycyrrhizic acid and its hydrolysate as mineralocorticoid agonist.
    Takeda R; Miyamori I; Soma R; Matsubara T; Ikeda M
    J Steroid Biochem; 1987; 27(4-6):845-9. PubMed ID: 2826910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone.
    Beaumont K; Fanestil DD
    Endocrinology; 1983 Dec; 113(6):2043-51. PubMed ID: 6227474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 19-Nor deoxycorticosterone (19-nor DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower.
    Funder JW; Mercer J; Ingram B; Feldman D; Wynne K; Adam WR
    Endocrinology; 1978 Oct; 103(4):1514-7. PubMed ID: 744165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships for agonistic and antagonistic mineralocorticoids.
    Genard P; Palem-Vliers P
    J Steroid Biochem; 1980 Nov; 13(11):1299-305. PubMed ID: 6256585
    [No Abstract]   [Full Text] [Related]  

  • 29. Aldosterone antagonists. 1. Synthesis and biological activities of 11 beta,18-epoxypregnane derivatives.
    Kamata S; Haga N; Mitsugi T; Kondo E; Nagata W; Nakamura M; Miyata K; Odaguchi K; Shimizu T; Kawabata T
    J Med Chem; 1985 Apr; 28(4):428-33. PubMed ID: 2984418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mineralocorticoid receptors in human kidney.
    Matulich DT; Spindler BJ; Schambelan M; Baxter JD
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1170-4. PubMed ID: 993320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors.
    Funder JW; Pearce PT; Smith R; Campbell J
    Endocrinology; 1989 Oct; 125(4):2224-6. PubMed ID: 2551643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mineralocorticoid and glucocorticoid receptors in circulating mononuclear leukocytes of patients with primary hyperaldosteronism.
    Armanini D; Witzgall H; Strasser T; Weber PC
    Cardiology; 1985; 72 Suppl 1():99-101. PubMed ID: 2996770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paradoxical differences in the receptor binding of two new antimineralocorticoids.
    Agarwal MK; Kalimi M
    Biochim Biophys Acta; 1988 Jan; 964(1):105-12. PubMed ID: 2825817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation of the mineralocorticoid target tissues to the high circulating cortisol and progesterone plasma levels in the squirrel monkey.
    Chrousos GP; Loriaux DL; Brandon D; Shull J; Renquist D; Hogan W; Tomita M; Lipsett MB
    Endocrinology; 1984 Jul; 115(1):25-32. PubMed ID: 6329650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physico-chemical characterization of cytosol and nuclear mineralocorticoid receptors in rat kidney.
    Palem-Vliers M; Hacha R; Saint-Remy A; Fredericq E; Genard P
    J Steroid Biochem; 1982 Mar; 16(3):457-61. PubMed ID: 6283271
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for an antagonist specific receptor that does not bind mineralocorticoid agonists.
    Lazar G; Agarwal MK
    Biochem Biophys Res Commun; 1986 Jan; 134(1):261-5. PubMed ID: 3004430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mineralocorticoid receptors during normal kidney growth and compensatory renal hypertrophy.
    Rafestin-Oblin ME; Claire M; Michaud A; Corvol P
    J Steroid Biochem; 1981 Apr; 14(4):337-40. PubMed ID: 6262570
    [No Abstract]   [Full Text] [Related]  

  • 38. Orally active mineralocorticoid agonists and antagonists: delta 1-derivatives of aldosterone and 18-deoxyaldosterone.
    Adam WR; Funder JW; Ulick S
    Endocrinology; 1981 Feb; 108(2):517-21. PubMed ID: 6256153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.
    Reul JM; de Kloet ER
    Endocrinology; 1985 Dec; 117(6):2505-11. PubMed ID: 2998738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of agonists and antagonists to mineralocorticoid receptors in human peripheral mononuclear leucocytes.
    Armanini D; Strasser T; Weber PC
    J Hypertens Suppl; 1985 Dec; 3(3):S157-9. PubMed ID: 2856694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.